Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

El Paso Q4 Net Profit Soars, Adj. EPS Up 40% - Quick Facts

El Paso Corp. (EP: Quote) reported a surge in its fourth-quarter 2011 net income attributable to EPC common stockholders to $185 million, or $0.24 per share from $62 million, or $0.09 per share a year earlier.

Adjusting for impacts of E&P financial derivatives and other items, quarterly adjusted earnings per share were $0.28, a 40 percent increase from $0.20 in the prior-year quarter. On average, 11 analysts polled by Thomson Reuters expected earnings per share of $0.29 for the quarter. Analysts' estimates typically exclude one-time items.

E&P production volumes for the latest quarter went up 11 percent from last year, averaging 880 million cubic feet equivalent per day or MMcfe/d, including 59 MMcfe/d of Four Star unconsolidated affiliate volumes.

Click here to receive FREE breaking news email alerts for El Paso Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Alaska Congressman Don Young, R-Ak., is once again making headlines with comments linking the state's high suicide rate to an increase in government assistance. Young told an audience at a senior center on Wednesday that the suicide problem didn't exist until there was "largesse" from the government. After moving sharply higher at the open, stocks have seen further upside over the course of the trading day on Thursday. The strong upward move on the day has more than offset the pullback that was seen in the previous session. Suggesting moderate growth in the short-term, the Conference Board released a report on Thursday showing that its index of leading U.S. economic indicators rose by more than economists had anticipated in the month of September.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.